CTNF 18/323,647 CTNF 84780 DETAILED ACTION Notice of Pre-AIA or AIA Status 07-03-aia AIA 15-10-aia The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA. Priority Acknowledgment is made of applicant’s claim for foreign priority under 35 U.S.C. 119 (a)-(d). Specification 06-16 AIA Applicant is reminded of the proper language and format for an abstract of the disclosure. The abstract should be in narrative form and generally limited to a single paragraph on a separate sheet within the range of 50 to 150 words in length. The abstract should describe the disclosure sufficiently to assist readers in deciding whether there is a need for consulting the full patent text for details. The language should be clear and concise and should not repeat information given in the title. It should avoid using phrases which can be implied, such as, “The disclosure concerns,” “The disclosure defined by this invention,” “The disclosure describes,” etc. In addition, the form and legal phraseology often used in patent claims, such as “means” and “said,” should be avoided. The abstract of the disclosure is objected to because the language “ Embodiments provide” and “SD-230173-YPC” should be deleted. The abstract should avoid using phrases which can be implied, such as, “The disclosure concerns,” “The disclosure defined by this invention,” “The disclosure describes,” etc. A corrected abstract of the disclosure is required and must be presented on a separate sheet, apart from any other text. See MPEP § 608.01(b). 06-31 AIA The lengthy specification has not been checked to the extent necessary to determine the presence of all possible minor errors. Applicant’s cooperation is requested in correcting any errors of which applicant may become aware in the specification. 07-29 AIA The disclosure is objected to because of the following informalities: Compounds 1 to 192 are not clear and needs to be darken in paragraph [00128] on page 20 of the disclosure. Compounds ETH1 to ETH20 are not clear and needs to be darken in paragraph [00220] on page 45 of the disclosure. It is unclear if the bond group is S, Si. Se or something else. Compounds HTH1 to HTH40 are not clear and needs to be darken in paragraph [00259] on page 55 of the disclosure. The compounds on page 143 are not clear and needs to be darken ( see HTH-1 to PS-2) . Appropriate correction is required. Claim Objections 07-29-01 AIA Claim 20 is objected to because of the following informalities: Compounds 1 to 192 in claim 20 are unclear and needs to be darken. For examples, there are bonds not showing and/or D substitutent is not clear on the ring . Appropriate correction is required. Claim Rejections - 35 USC § 112 07-30-02 AIA The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. 07-34-01 Claims 1-20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Independent claims 1 and 20 recite “a heterocyclic compound represented by Formula 1:… wherein X 1 is N(R 4 ), O, or S , X 2 is N (R 5 ), O, or S, at least one of X 1 and X 2 is each independently a group represented by one or Formulae 2-1 to 2-4 , …” The claims as written are indefinite and unclear. Applicants have define the meaning of X 1 and X 2 with multiple definitions. It is not clear what applicants intends to define the substitutent of X 1 and X 2 as in the present claims. Appropriate correction is required. Examiner suggests applicants to add the term “and” or “or” after “ X 2 is N (R 5 ), O, or S,”. For purposes of examination , the examiner is consider X 1 and X 2 to have either meaning so “or”. Claim 5 recites “ The light-emitting device of claim 4, wherein the emission layer further comprises at least one of a first host represented by Formula 5, … wherein in Formula 5, X 54 to X 56 are each independently C(R 50 ), CH or N, … R 50 to R 53 are each independently the same as described in connection with R 1 to R 10 in Formula 1, ….” The claim as written is indefinite and unclear. It is noted that in Formula 1 that R 1 to R 10 are each independently hydrogen; therefore, when R50 is hydrogen then “CH” is repetitive choice for X 54 to X 56. Appropriate correction is required. Examiner suggests deleting “CH”. Claims 2-9 depends on claim 1 and claims 11-20 depends on claim 10; therefore, the claims are also indefinite and rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA), second paragraph. Appropriate correction is required. Claim Rejections - 35 USC § 102 07-06 AIA 15-10-15 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. 07-07-aia AIA 07-07 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – 07-08-aia AIA (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. 07-15 AIA Claim (s) 1-4 and 6-15 are rejected under 35 U.S.C. 102( a)(1 ) as being anticipated by Hatakeyama et al. (WO 2017188111 A1; citations from English US 2019/0207112 A1) . Regarding claims 1-4 and 6-15, Hatakeyama et al. teach a light emitting device ( an organic electroluminescent element; [0013 & 0160] and figures) comprising: a pair of electrode ( a first and second electrodes i.e., anode and cathode electrodes); and interlayer ( a light emitting layer comprising an emission layer ; [0014] and abstract, claims and examples ) disposed between the pair of electrodes and heterocyclic compound represented by formula (I-2625): PNG media_image1.png 149 304 media_image1.png Greyscale wherein X 0 is B, X 1 is N(R 4 ) wherein R 4 is a C3- C60 carbocyclic group unsubstituted, and X 2 is N(R 5 ) wherein R 5 is a C3-C60 heterocyclic group substituted with at least one R10a wherein R10a is C3-C60 carbocyclic group and/or at least a group represented by one of Formulae 2-1 to 2-4 , wherein Y1 is N (R10) meeting the limitation as instantly claimed. The device further includes a hole transport layer ( hole transport region) which comprises a hole injection layer and electron transport layer ( electron transport region) comprises electron injection layer ( [0160] and figures). Also, Hatakeyama et al. teach an electronic apparatus ( flat panel display, sign, automotive (vehicle) panel, and flexible displays) comprising light-emitting device (Organic EL element; [0353-0359]. Prior Art 07-96 AIA The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See Cha et al. (WO 2021/010656 A1; see abstract, claims, drawings and examples) teach a heterocyclic compound and an organic light emitting element . Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHANCEITY N ROBINSON whose telephone number is (571)270-3786. The examiner can normally be reached Monday-Friday (8:00 am-6:00 pm; IFP; PHP). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anthony Zimmer can be reached at 571-270-3591. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHANCEITY N ROBINSON/Primary Examiner, Art Unit 1737 Application/Control Number: 18/323,647 Page 2 Art Unit: 1737 Application/Control Number: 18/323,647 Page 3 Art Unit: 1737 Application/Control Number: 18/323,647 Page 4 Art Unit: 1737 Application/Control Number: 18/323,647 Page 5 Art Unit: 1737 Application/Control Number: 18/323,647 Page 6 Art Unit: 1737 Application/Control Number: 18/323,647 Page 7 Art Unit: 1737
Prosecution Insights